Do Analysts Agree Friday on Exela Technologies Inc (XELA) Stock's Target Price? – InvestorsObserver
Analysts who follow Exela Technologies Inc (XELA) on average expect it to increase 968.18% over the next twelve months. Those same analysts give the stock an average rating of Buy. That average rating earns Exela Technologies Inc an Analyst Ranking of 30, which means it ranks higher than 30 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.
What’s Happening With Exela Technologies Inc Stock Today?
Exela Technologies Inc (XELA) stock is flat -1.09% while the S&P 500 has risen 0.23% as of 2:49 PM on Friday, Jul 8. XELA is flat $0.00 from the previous closing price of $0.11 on volume of 125,825,968 shares. Over the past year the S&P 500 is down -9.47% while XELA is lower by -96.07%. XELA lost -$0.93 per share the over the last 12 months. Click Here to get the full Stock Report for Exela Technologies Inc stock.
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You’re all set to receive the Morning Update newsletter
Stock Price data may be delayed up to 15 minutes.
Copyright © 2022. Portions of this content may be copyrighted by Fresh Brewed Media, Investors Observer, and/or O2 Media LLC. All Rights Reserved. Portions of this content protected by US Patent numbers 7,865,496, 7,856,390, and 7,716,116. Investing in stocks, bonds, option and other financial instruments involve risks and may not be suitable for everyone. Portfolio results are unaudited and based on varying investment expiration dates. Terms of Service | Privacy Policy